Eco-Med Pharmaceuticals Inc. yesterday recalled a nonsterile ultrasound gel distributed under various brand names, including EcoGel and MediChoice, instructing health care facilities to immediately destroy or return the products due to contamination with the bacteria Burkholderia cepacia complex (Bcc).

The Centers for Disease Control and Prevention is assisting the Food and Drug Administration and several state and local health departments with an ongoing investigation of Bcc infections in health care facilities. It said patients have developed Bcc infections (including bloodstream infections) after ultrasound-guided procedures that used the MediChoice M500812 ultrasound gel.

CDC advises health care facilities to always use single-use, sterile ultrasound gel packets for ultrasonography used in preparation for or during transcutaneous procedures, such as placement of central and peripheral intravenous lines, amniocentesis and paracentesis. This includes avoiding nonsterile ultrasound gel for visualization prior to such procedures (e.g., vein marking, visualizing ascites). 

Health care facilities should report any patient infections to FDA’s MedWatch program

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…